Publications

Neoplasia

A G-quadruplex stabilizer, CX-5461 combined with two immune checkpoint inhibitors enhances in vivo therapeutic efficacy by increasing PD-L1 expression in colorectal cancer

Jan

31

2023

Hepatology

Silmitasertib plus gemcitabine and cisplatin first-line therapy in locally advanced/metastatic cholangiocarcinoma: A Phase 1b/2 study

Sep

24

2022

Nature Communications

Results of the phase I CCTG IND.231 trial of CX-5461 in patients with advanced solid tumors enriched for DNA-repair deficiencies

Jun

24

2022

Signal Transduction and Targeted Therapy

Protein kinase CK2: a potential therapeutic target for diverse human diseases

Jul

20

2021

ACS Publications

Integrating Proteomics for Facilitating Drug Identification and Repurposing During an Emerging Virus Pandemic

Dec

17

2020

Cellular Oncology

Role of CK2 inhibitor CX-4945 in anti-cancer combination therapy – potential clinical relevance

Oct

14

2020

nature genetics

Landscape of G-quadruplex DNA structural regions in breast cancer

Aug

03

2020

Cell

The Global Phosphorylation Landscape of SARS-CoV-2 Infection

Jun

28

2020